JW Lifescience Corporation (KRX:234080)

JW Lifescience Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	9,005	8,379	7,511	20,222	3,920	4,923
Short-Term Investments	3,074	2,110	2,110	8,126	24,953	155.05
Cash & Short-Term Investments	12,079	10,489	9,622	28,348	28,873	5,078
Cash Growth	-55.74%	9.01%	-66.06%	-1.82%	468.59%	95.88%
Accounts Receivable	40,625	43,436	43,048	55,505	53,426	32,141
Other Receivables	-	1,344	16,784	252.42	346.01	257.79
Receivables	40,625	44,780	59,832	55,757	53,772	37,198
Inventory	29,130	31,622	35,448	23,399	22,067	21,077
Prepaid Expenses	-	131.29	159.78	24.78	236.47	1,044
Other Current Assets	168.67	1,266	602.96	305.56	60.7	32.79
Total Current Assets	82,003	88,289	105,664	107,834	105,008	64,430
Property, Plant & Equipment	124,481	128,653	132,051	124,577	131,555	137,145
Long-Term Investments	589.87	582.85	558.57	10,419	4,390	8,934
Goodwill	32,389	32,389	74,266	950.99	950.99	950.99
Other Intangible Assets	43,943	44,490	3,220	2,870	3,100	3,671
Long-Term Deferred Tax Assets	-	-	-	15.81	-	-
Long-Term Deferred Charges	164.31	192.47	248.81	305.14	484.8	689.12
Other Long-Term Assets	22,214	23,610	9,315	8,865	7,453	3,646
Total Assets	305,784	318,206	325,324	255,836	252,942	219,467

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	18,507	16,900	19,617	18,740	15,118	12,496
Accrued Expenses	-	1,540	1,669	1,271	1,156	724.7
Short-Term Debt	30,500	17,800	27,700	15,700	36,681	44,350
Current Portion of Long-Term Debt	-	31,137	8,112	30,353	336	336
Current Portion of Leases	380	296.15	350.82	44.91	131.02	159.77
Current Income Taxes Payable	3,592	2,046	8,594	2,739	3,645	3,279
Other Current Liabilities	12,495	14,707	14,136	25,411	22,976	22,557
Total Current Liabilities	65,475	84,428	80,179	94,259	80,044	83,902
Long-Term Debt	-	-	31,899	168	30,007	1,610
Long-Term Leases	1,486	1,339	1,176	46.68	40.42	31.91
Pension & Post-Retirement Benefits	4,351	4,050	4,001	-	-	-
Long-Term Deferred Tax Liabilities	7,617	7,728	7,406	1,828	2,011	2,243
Other Long-Term Liabilities	92.09	82.81	217.94	141.95	508.07	187.8
Total Liabilities	79,021	97,628	124,879	96,443	112,610	87,975

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	39,586	39,586	39,586	39,586	39,586	39,586
Additional Paid-In Capital	28,335	28,335	28,335	28,335	28,335	28,335
Retained Earnings	159,102	152,918	132,422	98,220	79,160	70,319
Treasury Stock	-6,749	-6,749	-6,749	-6,749	-6,749	-6,749
Comprehensive Income & Other	6,487	6,487	6,850	0	0	0
Shareholders' Equity	226,763	220,578	200,445	159,393	140,332	131,492
Total Liabilities & Equity	305,784	318,206	325,324	255,836	252,942	219,467

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	32,366	50,573	69,238	46,313	67,195	46,488
Net Cash (Debt)	-20,286	-40,084	-59,616	-17,965	-38,322	-41,410
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-1310.08	-2588.63	-3850.39	-1160.20	-2474.87	-2657.82
Filing Date Shares Outstanding	15.5	15.48	15.48	15.48	15.48	15.48
Total Common Shares Outstanding	15.5	15.48	15.48	15.48	15.48	15.48
Working Capital	16,528	3,861	25,485	13,574	24,965	-19,472
Book Value Per Share	14628.55	14245.04	12944.82	10293.69	9062.74	8491.82
Tangible Book Value	150,431	143,699	122,959	155,573	136,281	126,870
Tangible Book Value Per Share	9704.37	9280.15	7940.73	10046.95	8801.12	8193.30
Land	41,313	41,313	41,313	32,459	32,459	32,459
Buildings	32,493	34,088	36,983	39,820	41,648	42,618
Machinery	47,031	50,040	49,269	51,450	56,836	44,976
Construction In Progress	1,817	1,599	2,987	758.47	440.73	16,903

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 22, 2026

Data Sources Report a data error